BlueOcean

BlueOcean

Created using Figma
Created using Figma
BlueOcean is an investment firm that has developed multiple funds over the past decade. These funds are tailored towards the MedTech (Medical Technology) industry. MedTech represents a massive industry in Europe alone, and is quite broad in its description. Those within the industry may be credited with developing next-gen pacemakers, atrial valves, insulin delivery vehicles, and even deep brain stimulation methods. BlueOcean recognizes not only the importance of this industry, but also the potential to both help and benefit it simultaneously.
To be announced
Token Details
Accepted Currencies
ETH, BTC, FIAT
Company Details
Registered Country
Singapore
Additional Details
KYC
Yes
Categories
Platform

About BlueOcean

With over 12,000 patents filed within MedTech in 2016, over 40% of these originated from Europe.  Furthermore, of the over $1 billion invested every year in Swiss startups, $600 million of this is funneled towards healthcare.  From these numbers, it is clear – MedTech is booming.

Unfortunately, due to the vast amount of money and companies entering the industry, it is a difficult process to filter which start-ups are truly promising, and which aren’t.  This process requires vast amounts of experience in various fields ranging from Medical to Legal, financial and more.

Another hurdle that must be cleared is the fact that many investment funds are unable to take part in private equity.

With each of these hurdles in place, despite the amount of money flowing into the industry, many of the best opportunities remain either hard to spot, or simply out of reach.

lueOcean Ventures is an investment firm that possesses experts in the following fields. By having a diverse cast of experts, the firm has a history of selecting successful start-ups.  Currently, this team is actively building their second fund.  This is known as the BlueOcean Ventures II.  This fund currently has holdings in 5 different companies within the MedTech industry.  The firm is looking to both expand and increase their holdings in these companies.

To achieve their goal of expansion and increased exposure, BlueOcean is hosting an STO.  This STO will allow accredited investors the ability to invest in pre-vetted start-ups.  This means that they can take advantage of the wide array of skills the BlueOcean team brings to the table.

By utilizing blockchain technology, the investors in the fund will benefit from not only increased transparency (where are the funds being spent), but also from increased levels of liquidity.  As there is no lock-up period on the BlueOcean tokens (BOV), investors will be able to trade their tokens on secondary markets in a short amount of time.  Tokens are expected to be listed on cryptocurrency exchanges by Q1 of 2019.

Features

With their STO currently active, BlueOcean will be preparing for token distribution.  Once complete, the funds garnered throughout the STO will be able to be put to use, and begin working for the investors that participated.  BlueOcean indicates that 100% of these funds will be invested in BlueOcean Ventures II.

For those looking to invest in MedTech start-ups via a curated fund, check out the BlueOcean STO;  The easiest way to gain indirect equity in these promising start-ups.

The fund is scheduled to close in 2025.  Upon closure, all assets will be proportionately divvied up among remaining investors.

BlueOcean Roadmap

  • 2008

  • Launch of BlueOcean Ventures I
  • 2015

  • Launch of the second fund, BlueOcean Ventures II
  • 2016

  • BlueOcean Ventures II invests in Ava AG, Rheon Medical SA, and Abionic SA
  • 2017

  • BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)
  • Read More
  • MAY 2018

  • Set up of Special STO Investment Vehicle in Singapore
  • JULY 2018

  • BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO
  • DECEMBER 2018

  • End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II
  • BEGINNING OF 2019

  • BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups
  • 2020/2021

  • BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company
  • 2025

  • BlueOcean Ventures II is closed, all remaining assets are distributed to the investors

Activity

Members:
75
VERY LOW
30 Days Growth:
-3
Alexa

Rank:
6 424 149
VERY LOW
Delta:
3 579 645

BlueOcean Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Emmanuel de Wattevil...
General Partner and Co-Founder
unverified
Thomas Zehnder
General Partner
unverified
Jean-Etienne Durand
Head of Operations
unverified
Lug Giroud
Head of Marketing
unverified
Christophe Saam
Swiss & European Patent Attorney
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Antonio Gambardella
Advisor
unverified
Olivier Crochat
STO Technology Advisor
unverified
N/A
5.0 13
STO Profile Vision Activity Potential Product Team
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO